From Genes to Biomarkers: Understanding the Biology of Malaria Gametocytes and Their Detection by Kepple, Daniel et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







From Genes to Biomarkers: 
Understanding the Biology of 
Malaria Gametocytes and Their 
Detection
Daniel Kepple, Anthony Ford, Ebony Little, 
Gabrielle Kolesar, Beka R. Abagero, Ashley N. Blackwell, 
Swarnapali De Silva Indrasekara, Delenasaw Yewhalaw  
and Eugenia Lo
Abstract
Each year, approximately 230 million malaria cases and 400,00 malaria 
deaths are reported worldwide. Malaria is a life-threatening disease caused 
by Plasmodium parasites that are transmitted from one individual to another 
through the bites of infected female Anopheles mosquitoes. Malaria parasites 
replicate asexually in the human host, and, in each replication cycle, a portion 
of the asexual stages develops into sexual gametocytes that permit transmission. 
The proportion of infections that carries gametocytes and the infectivity of 
gametocytes are indicators of human-to-mosquito transmission potential. In P. 
falciparum, gametocytes appear 10–14 days after infection, whereas in  
P. vivax gametocytes appear simultaneously with asexual schizonts. Such dif-
ference in development not only increases the length of time that an individual 
is infectious, but also increases the likelihood of transmission before treatment. 
The conversion from asexual parasites to gametocytes is also highly variable 
between infections. Differences in age, host immune response, parasite genetic 
composition, density of red blood cells, presence of co-infecting parasite strains, 
and antimalarial drug use could affect gametocytes production. In  
P. vivax, the unique ability to produce hypnozoites, a dormant liver stage of the 
parasite, may allow gametocytes to be produced periodically from relapse and 
contribute to transmission. In this chapter, we will provide an overview of the 
biology of Plasmodium gametocytes, existing tools for gametocyte detection, 
and features of gametocyte genes. The biological insights and genetic findings 
are essential to developing better detection biomarkers and effective strategies to 
reduce transmission in malaria-endemic countries.
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Malaria is a mosquito-borne disease. In humans, malaria is primarily caused by 
six different Plasmodium parasite species including P. falciparum, P. vivax, P. ovale, 
P. malariae, P. knowlesi, and P. simium [1]. To date, there is an estimated 229 million 
cases of malaria worldwide each year resulting in approximately 409,000 deaths [2]. 
This has resulted in an estimated direct cost (treatments, premature death, and loss 
of household income) of $12 billion USD per year, with lost economic growth being 
many times greater [3]. The deadliest of these is P. falciparum, primarily located in 
the African continent [4], due to the high parasitemia levels and rapid growth [4]. 
P. falciparum utilizes several host receptors, including Band 3 and Glycophorin A, 
B, and C for red blood cell invasion [5], which contributes to high parasite loads in 
infected patients and spread across the ethnically diverse continent. Contrary to P. 
falciparum, P vivax primarily uses the Duffy antigen receptor found on the surface 
of reticulocytes for invasion, leading to lower parasitemia levels. P. vivax is globally 
widespread in Asia, South America, and northern and eastern parts of Africa [6]. 
This parasite can cause relapse from weeks to months after the initial infection [6].
Most P. ovale cases were reported in the tropics of western Africa [7] and is consid-
erably less prevalent and possibly less fatal in comparison to P. falciparum and P. vivax 
[8]. P. ovale has two different subspecies: P. ovale curtisi and P. ovale wallikeri, both of 
which may produce dormant stage hypnozoites similarly to P. vivax [9, 10]. P. ovale has 
been shown to be transmitted across international borders from Africa to China [11] as 
well as to Korea [11, 12], in countries that were considered malaria free [12]. P. malar-
iae is mostly reported in sub-Saharan Africa and southeast Asia. Similar to P. ovale, P. 
malariae is less common and less fatal. In sub-Saharan Africa, infections of P. malariae 
are often found to also contain P. falciparum [13]. Though less common, P. knowlesi, 
a primate parasite infecting long-tailed and pig-tailed macaques [14], has recently 
been reported to infect humans in Southeast Asia [15, 16] and is mainly transmitted 
by Anopheles leucosphyrus and A. hackeri [16–18]. P. knowlesi utilizes two gene families: 
DBL and RBP, to bind the Duffy antigen/chemokine receptor (DARC) to invade 
human erythrocytes [19]. Last but not least, P. simium is a common primate parasite 
that has recently been detected through molecular assays in humans from Atlantic 
Forest region of southeastern Brazil [20]. P. simium remains largely uncharacterized 
due to its novelty and rarity in humans, but is thought to have similar invasion mecha-
nisms to P. vivax due to genetic and morphological similarities [20]. The presence of 
these less-common malarial species emphasizes the need for better detection tools and 
control measures especially in countries approaching the elimination phase.
1.2 Development and transmission of Plasmodium
The lifecycle of Plasmodium is divided into two stages: the human asexual 
reproduction stage (also known as the erythrocytic stage) and the mosquito sexual 
reproduction stage (known as the sporogonic cycle) [20], both of which are neces-
sary for population growth and genetic diversification [19]. The parasite first enters 
the human body in the form of sporozoites through the infected salivary gland of 
an Anopheles mosquito during a blood meal. Within minutes, sporozoites infect the 
liver and begin asexual replication to form schizonts (a process called exoerythro-
cytic schizogony) within a few days to a few weeks [20]. Once matured, schizonts 
bust to release hundreds of merozoites into the blood stream [20]. P. falciparum,  
P. ovale, P. malariae, and P. simium infect mature erythrocytes [2, 19, 21] while 
P. vivax and P. knowlesi infect younger reticulocytes [2, 19, 22–24] to feast on 
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hemoglobin and further reproduce asexually [2, 19]. At this stage, the intracellular 
Plasmodium is considered as a ring stage parasite because the young parasite takes 
up hemoglobin in a single, large vacuole that looks like a ring. Once the hemoglobin 
is engulfed, the parasite then begins feeding and hemoglobin is acquired by endocy-
tosis of erythrocyte cytoplasm within cytostomes, known as the trophozoite stage. 
After the hemoglobin is consumed, the trophozoite may either undergo schizogony 
to asexually reproduce and start the erythrocytic cycle with new merozoites or 
mature into a macrogametocyte (egg) or microgametocyte (sperm). Because 
human body temperature is considerably warm for Plasmodium sexual reproduc-
tion [25], both forms of gametocytes are taken up by an Anopheles mosquito where 
sexual reproduction occurs within the gut of the mosquito producing zygotes. Once 
matured, the zygote will become mobile and elongated, developing into ookinete 
to infect the midgut wall of the mosquito [26] and develop further into oocyst. 
Oocysts asexually divide and eventually rupture into sporozoites that travel to the 
salivary gland of the mosquito to infect a new human host [2, 19].
All six human malaria parasites require gametocytes to infect female Anopheles 
mosquito to reproduce sexually and continue development into sporozoites before 
infecting a new human host [27]. This has led to complications in the control of 
malaria transmission and gametocyte detection [28]. Furthermore, P. vivax and  
P. ovale’s unique ability to form dormant stage hypnozoites complicates parasite 
clearance and can reintroduce old parasite strains into transmission reservoirs [2, 
19]. Gametocytes are critical for malaria transmission and possible immune evasion 
in both the human and mosquito hosts [29, 30], emphasizing the importance of 
accurate detection. This chapter aims to provide a systemic review that highlights the 
complexity of Plasmodium gametocytes at the biological and genetic levels and cur-
rent methods used to track and detect Plasmodium gametocytes. We further examine 
the capability of biomarkers used across Plasmodium species and provide new 
candidate biomarkers to further enhance detection protocols. Lastly, we examine the 
immunogenicity of gametocytes in both humans and mosquitoes.
2. Gametocytogenesis
2.1 Gametocyte commitment and development
Gametocytogenesis is the commitment of a Plasmodium parasite to produce 
male and female gametocytes through mitotic division during the trophozoite stage 
that involves multiple epigenetic and transcriptional regulations [31]. Changes in 
temperature, pH, and host age help stimulate gametogenesis, the emergence of the 
gametes in the mosquito mid-gut. A drop in temperature from 38°C to 20-26°C, the 
exposure to gametocyte activating factors and/or mosquito exflagellation factors, as 
well as a rise in pH can trigger gametogenesis [32–34]. Some merozoites, for reasons 
not fully understood, differentiate into the sexual forms of the parasites, the game-
tocytes. Upon ingestion by the mosquito, the decline in pH, a drop in temperature, 
and other mosquito derived factors such as xanthurenic acid can together activate 
gametocytes to transform within 5–10 minutes to male (microgamete) and female 
gametes (macrogamete) within the mosquito midgut. When gametocytes are taken 
up during a mosquito’s blood meal, a number of factors including temperature, 
oxygen and carbon dioxide concentration, pH and exflagellation factor contribute 
to the maturation of gametocytes [35]. Some species, such as P. ovale in humans and 
P. yoelii in mice, can develop into morphologically distinct male and female game-
tocytes directly from hepatic merozoites for further transmission [7]. Gametocyte 
commitment is largely based on stress factors including high parasitemia, anemia, 
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drug treatments, and host immune responses [36–39]. Although no clinical symp-
toms are experienced during gametocytogenesis, this developmental stage is critical 
for sexual replication in the mosquitoes and subsequent infection of a new human 
host in the form of sporozoites. There is considerable variation in the development 
time among the different human Plasmodium species, ranging from 7 to 10 days 
after the initial establishment of asexual parasites for P. falciparum [40] and 
7–15 days for P. vivax [41]. It is yet unclear about the time for gametocyte develop-
ment in P. knowlesi, P. malariae, P. ovale, and P. simium. During this prolonged 
maturation period, gametocytes undergo five morphologically distinct stages (I-V) 
[42]. The immature gametocytes developed during stages I-IV sequester mostly 
in host tissues, particularly in bone marrow and spleen [43]. At stage V during 
maturation, gametocytes become more deformable and return in the blood circula-
tion for uptake by a new mosquito host [44]. For proper sporogonic development 
to occur, both male and female gametes must be taken up during a blood meal as 
merozoites are incapable at forming both male and female gametocytes from the 
same schizont [45]. Most regulation is performed through RNA binding proteins, 
such as acetylation lowers binding efficiency 4 (ALBA4), that increases exflagella-
tion events in an unknown manner [46, 47].
To date, most of our knowledge on gametocyte commitment is derived from 
P. falciparum due to a lack of viable culturing methods for P. vivax [48] and low 
prevalence of other Plasmodium species. Molecular processes including epigenetic 
regulation and histone posttranslational modifications play vital roles in gametocyte 
commitment [49–51]. A well-studied example of histone regulation in P. falciparum 
is H3K9me3, which is normally restricted to multigene families in subtelomeric 
regions [52], and recruits heterochromatin protein 1 (HP1) [53, 54]. Both proteins 
are strongly associated with the AP2-G locus, the primary regulator for gametocy-
togenesis [55, 56]. Previous studies have shown that a majority of asexual parasites 
have AP2-G silenced [47] and this gene silencing may be induced by histone deacety-
lase (Hda2) [57]. Depletion of HP1 through GDV1, another gene that regulates 
gametocyte production, was shown to increase schizont development into gameto-
cytes by 50% [47, 58]. Further, the presence of Stabilization ligand Shield 1 (Shld1) 
may also increase transcription of AP2-G by stabilizing the protein complex for 
transcription and enhance gametocyte production. Although the molecular mecha-
nisms of gametocytogenesis are well established in P. falciparum, there are currently 
no sensitive and reliable methods available in clinical settings for front-line detection 
of in vivo gametocytes due to strain polymorphisms, limiting gametocyte densities, 
and variations in the timing of gametocyte production and development.
2.2 Polymorphisms of gametocyte genes
Recently, advances in next generation sequencing provide new insights in our 
understanding of genetic variation and gene expression across different stages of 
Plasmodium species [59]. The mosquito immune system is a significant barrier for 
some Plasmodium isolates to infect the mosquito hosts. For example, in P. falci-
parum, highly expressed Pfs47 protein allows the parasites to become “invisible” 
and escape the immune system of the mosquito. This protein is expressed on the 
surface of female gametocytes and ookinetes. The African isolates of P. falciparum 
that are known to express Pfs47 have been shown to escape the Anopheles gambiae 
immune system by suppressing the Jun-N-terminal kinase (JNK) signaling and 
avoiding the induction of epithelial nitration [59]. The Pfs47 protein gene is highly 
polymorphic implying that the mosquito immune system may be the driving force 
for diversity, and that parasites with compatible Pfs47 haplotypes and/or escape 
immune evasion are preferably selected [60].
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The innate immune response in the mosquito vector is mediated in most part by 
the hemocytes, which eliminate pathogens such as bacteria, fungi, and protozoa. 
Anopheles mosquitoes are known to have a complement C3-like protein called 
thioester-containing proteins (TEP). TEP of An. gambiae (AgTEP1) has been shown 
to initiate immune defense against P. berghei [61]. TEP1 facilitates the interaction 
between the parasite and hemocytes with late encapsulation that kill the parasite. 
Knockdown of the TEP1 gene renders genetically selected refractory Anopheles 
strain susceptible to infection and increases the infectivity rates [61]. However, P. 
falciparum has been shown to bypass the TEP-based defense mechanism using its 
6-cystein protein P47-like [61]. In P. berghei, the P47-like protein is important for 
female gamete fertility, whereas in P. falciparum, it promotes the gametocyte-to-
ookinete development and protects the ookinete from complement-dependent lysis 
[61]. Furthermore, infection of An. gambiae mosquitoes by ookinetes of P. berghei 
has been shown to module the mosquito’s immune system by up-regulating expres-
sion of the peptide defensin and a putative gram-negative bacteria-binding protein 
and a TNF-α factor-like transcription factor (LL3) [61].
2.3 Expression of gametocyte genes
During the different stages of gametocyte development, various genes express 
differentially. For instance, Pfs16 expresses the earliest and highest in stage II game-
tocytes, the alpha-tubulin II gene shows maximum expression levels in both stage II 
and III gametocytes, Pfs230 expresses in stage III gametocytes, PfsMR5 in stage IV 
gametocytes, and Pfs28 in stage V gametocytes [62]. Such gene expression pattern 
is directly related to the activities involved in each specific stage. Pfs16 is known as 
a marker for detecting sexually committed ring stages parasites and it likely plays a 
key role in gametocyte maturation given its continual expression during the entire 
gametocyte maturation process [63]. Recent immunofluorescences assay identi-
fied a small population of schizonts that expressed the Pfs16 gene. Pfs16 mRNA 
increases in the asexual cycle before schizonts develop into stage I gametocytes, 
though translation is delayed until the onset of stage I gametocytogenesis [62]. This 
finding suggests that both Pfs16 transcription and translation may begin prior to 
invasion of a committed merozoite and development into a stage I gametocyte.
The female gametocyte specific gene Pfs25, which expresses solely in the mosquito, 
is a glycosylphosphatidylinositol-linked protein expressed on the surface of ookinetes 
[64]. This gene is used for the detection of stage V female mature gametocytes as well 
as in the quantification of gametocytes from field studies [63]. Because Pfs25 is solely 
expressed inside the mosquito hosts with limited immune selective pressure, sequence 
variation between isolates is relatively low [65]. Antibodies against Pfs25 have been 
shown to reduce oocyst production in in vitro membrane feeding experiments. Both 
high sequence conservation and antibody response make Pfs25 a leading target for 
transmission-blocking vaccine design. Apart from Pfs25, another family of gameto-
cyte protein with cysteine-rich domains includes Pfs230 and Pfs48/45 that have also 
been targets of transmission-blocking vaccine  development [66, 67].
Pfs230 expresses in both male and female gametocytes with a prodomain that is 
processed during gametocytogenesis and mediates red blood cell binding, specifi-
cally during oocyst development [68]. The Pfs230 protein appears on the surface of 
gametes as a complex with Pfs48/45 (a glycosylphosphatidylinositol (GPI) anchored 
protein [69]) and appears to be critical for gamete fusion. The double domains in 
Pfs230 reveal a structure resembling the surface antigen 1 (SAG1) protein with a 
double beta-sandwich structure found in Toxoplasma gondii, another apicomplexan 
parasite. The complete gene encoding the Pfs230 protein from different isolates 
of P. falciparum showed that 27 nonsynonymous polymorphic sites [70]. Among 
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them, the amino acids at eight polymorphic sites map to positions that point their 
side chains toward the surface of the protein [70]. Five of those eight sites map to 
a confined region on the same side of the beta-sandwich of the protein structure. 
Even though the distribution of the amino acids are over much of the length of the 
domain IV sequence, the polymorphic sites appear to outline, although loosely, a 
contiguous surface region of the model [70]. This structural feature may provide 
relevant sites with respect to the interaction of male and female gametes [70].
In both male and female gametocytes, Pfs230 is expressed without a known 
membrane anchor and appears as a complex with the Pfs48/45 proteins on the 
surface of gametes, though this colocalization is not required. Pfs230 has been 
observed on the surface of live macrogametes in the absence of Pfs48/45 [71]. 
Pfs48/45 is a cysteine rich surface protein that is vital in male gamete fertility. 
Sequence analyses of Pfs48/45 revealed that polymorphisms are rare for residues 
involved at the binding interface [72]. Furthermore, unlike other pre-erythrocytic 
blood stage antigens Pfs48/45 is less polymorphic. The number of synonymous 
substitutions per synonymous site exceeds the number of non-synonymous substi-
tutions per non-synonymous site [73].
Recent clustering analyses indicated that there is a clear distinction in the 
expression levels between male and female gametocyte genes. Male and female 
gametocytes have been shown to be differentiated by their gene expression levels 
as early as stage III. The female gametes are generally separated by stage, indicating 
differentiating gene expression levels with respect to mid and late-stage female 
gametocytes [74]. For male gametocytes, PF3D7_1325200, a putative lactate 
dehydrogenase gene, is highly expressed [74]. Another male gametocyte gene 
PF3D7_1311100 is a putative meiosis-specific nuclear structure protein 1. This gene 
is essential for normal assembly of the sperm flagella in mice, suggesting that it 
may have a role in the male gamete development and exflagellation. Other genes 
including Pf3D7_1114000, Pf3D7_1122900, Pfg14–748, HAP2, and MAPK2 are 
found to be associated with male gametocytes, though both Pf3D7_1114000 and 
Pf3D7_1122900 are also expressed in a few female gametocytes [74].
3. Genetic markers for detection and prevention
3.1 Conventional genes used for gametocyte detection
Previous study has indicated that approximately 10% of P. falciparum and 60% 
of P. vivax infections had concurrent detectable low-density gametocytemia [75]. 
Gametocyte densities are typically lower than asexual parasite densities (Figure 1A) 
and directly associated with total asexual parasite densities (Figure 1B). Given the 
relatively low gametocyte densities, it is conceivable that many of these infections 
are submicroscopic and remain undetected in communities where malaria occurs, 
contributing to continuous transmission.
Molecular tests for diminutive amounts of gametocytes use reverse-tran-
scription polymerase chain reaction (RT-PCR) to amplify RNA transcripts of 
gametocyte-specifically expressed genes. Compared to DNA-based assay, qRT-PCR 
of targeted RNA transcripts revealed higher sensitivity in detecting gametocytes 
of considerably low densities. For example, there are more than 106 copies of 18S 
rRNA transcript per cell but only 5 copies of the 18 s rRNA gene per genome [76]. 
The production of high transcript copies in parasite cells allow for greater detec-
tion limits. For P. falciparum, several targeted genes such as Pfs25, Pfg136, Pfg84, 
and Pfg17 are specific to female gametocytes. The lack of genes specific to male 
gametocytes could underestimate the total gametocytes in an infection and thus 
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its transmission potential. Moreover, genes often show wide variations in detec-
tion limit based on the level of RNA transcript production, ranging from 100 
gametocytes per microliter of blood by Pfg84, 70.7 gametocytes/μL by Pfg136, 25.3 
gametocytes/μL by Pfs25 to as low as 10 gametocytes/μL by Pfg17 [77]. Pfg17 is 
considered as the most sensitive biomarker so far because it can detect the lowest 
number of gametocytes. For example, in malaria-endemic areas of Ghana, Pfg17 
offers higher sensitivity than Pfs25 in detecting P. falciparum gametocytes in clinical 
samples collected from children and adults [61]. Of the 80 children, 47 were tested 
negative and 33 were positive for asexual blood stage P. falciparum. Nine out of the 
47 (19%) negative children were detected positive for P. falciparum gametocytes by 
Pfg17. Among 30 adults aged from 32 to 60 years, 21 were (70%) tested positive for 
P. falciparum gametocytes by Pfg17, but only 7 (23.3%) were positive by Pfs25 [61].
For P. vivax, Pvs 25 and Pvs16 that are specific to female gametocytes are two 
conventional gene markers for gametocyte detection [78]. One gametocyte roughly 
corresponds to four Pvs25 transcripts per cell [79], and Pvs25 can detect from a mean 
of 0.34 gametocytes per μL blood from P. vivax patients in Papua New Guinea [78] 
to a mean of 2 gametocytes per μL blood in patients from Ethiopia [75]. Such low 
gametocyte densities make them extremely difficult to be detected by microscopy. The 
number of Pvs25 gene transcript copes detected by qRT-PCR directly correlates with 
the number of mature gametocytes as well as the overall parasite densities [41, 80] and 
was shown a nearly normal distribution with a mean of 1.2 × 107 copies/μL (ranging 
from 1.1 to 4.8 × 108 copies/μL) blood among 42 symptomatic P. vivax patients from 
northwestern Brazil [81]. Prior studies showed that age is tightly associated with game-
tocytemia. A lower proportion of infections with gametocytes was found with increas-
ing age [79, 82]. Gametocytes are generally detected in ~20% of the infections among 
adults [41], but at much higher proportions in children under the age of 12 [82, 83]. 
Yet, gametocytemia in adults is up to 20-fold higher than in children [84, 85]. In areas 
with low levels of transmission, a large proportion of infections that are undetected by 
microscopy could be reservoir for parasites with high infectious gametocytes [86]. In 
Ethiopia, symptomatic P. vivax infections are nearly four times more infectious than 
asymptomatic ones [87]. Other factors such as host immune response, parasite strains, 
red blood cell density, antimalarial drug use, and relapse can also affect gametocyte 
production [79, 88, 89]. For P. malariae and P. ovale, there is yet no gametocyte assays 
due to little success in finding Pfs25 or Pvs25 orthologues in these species.
Figure 1. 
(A) Comparison of asexual parasitemia and gametocytemia among P. vivax infections from Ethiopia. (B) 
Significant correlation was observed between asexual parasitemia and gametocytemia.
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3.2 Novel gene candidates to improve detection sensitivity
Recently, the male-specific gene pfs13 that offers the lowest female to male 
expression ratio was identified as a new male gametocyte biomarker used in 
qRT-PCR assays from field isolates [90]. Other male-specific markers including 
PF3d7_1311100, PF3D7_1325200, and Pfg14–748 were also shown with abundant 
stage V male gametocytes in infected samples that made them as sensitive biomarker 
candidates [74], although their specific functions are unclear. Furthermore, CCp1, 
CCp3, and P25 were identified as better biomarkers in differentiating female from 
male gametocytes [74, 91]. These genes are highly expressed in stages III to V female 
gametocytes. Though another gene NEK4 is female-specific, it is not sufficiently 
expressed in the transcriptome until stages IV and V, suggesting that it could be a 
good late-stage female biomarker candidate. PF3d7_1107800, a putative AP2 tran-
scription factor, also strongly correlates as a female specific gametocyte gene similar 
to NEK4. PF3d7_1107800 is highly expressed only during stages IV and V, and 
thus, could potentially a biomarker for late-stage female gametocyte detection [74]. 
Besides, female gametocyte marker gene CCp4 was also identified as a new target 
for gametocyte detection [92]. The design of intron-spanning primers of these novel 
genes allows for the amplification of mRNA only without a DNA digestion step [92].
A recent study of 26 P. vivax samples from Cambodian patients indicated that the 
expression profile of 21 predicted gametocyte genes were clustered in two distinct 
groups [93]. One group includes Pvs25, ULG8, gametocyte developmental protein 1, 
guanylate kinase, HMGB1, and five CPW-WPC proteins that associate with intracel-
lular trafficking and histone remodeling in the female gametocytes. The other group 
includes Pvs47, Pvs48/45. Hap2, the gamete egress and sporozoite traversal protein, 
s16, and three CPW-WPC proteins that associate with microtubular development in 
the male gametocytes. It remains to be determined if these male and female game-
tocyte genes show higher expression than the conventional marker Pvs25, offer high 
detectability of the total potentially transmitting gametocyte densities (both male 
and female gametocytes), and allow for robust gametocyte sex-ratio estimates in 
field studies given their stability under suboptimal storage conditions [92].
3.3 Treatment and prevention
In P. falciparum infections, gametocytes express surface antibodies against the 
surface antigens for circumsporozoite protein (PfCSP) 2A10, apical membrane 
antigen 1 (PfAMA1), and thrombospondin-related adhesive protein (TRAP). In P. 
vivax infections, Pvs48/45 and PfCLAG9 have been shown to elicit naturally acquired 
immune responses [65, 66]. Gene 1613 has been identified to be critical for the develop-
ment and maturation of gametocytes, which could potentially impact the elicitation 
of humoral immune response and the ability of gametocytes to transmit [94]. These 
could be critical antigen proteins for vaccine design. As gametocytes mature from one 
stage to another, the production of antibodies in human hosts will cause gametocytes 
to develop and mature at a much slower rate than normal in the bone marrow [94–96]. 
Combining multiple antigens involved in different stages of gametocyte development 
and sexual progression can help interfere and diminish transmission [69]. Predicting 
the structure of the parasite antigen binding domains e.g., in AMA1 and Pfs48/45, and 
delineating epitopes targeted by the host antibodies could uncover key elements in 
blocking transmission and provide a benchmark for evaluating vaccine efficacy [70]. 
Vaccines that block the ability of gametocytes to transmit can reduce infections and 
lower the transmission potential from mosquitoes to humans in malaria-endemic areas 
[67]. Future studies should focus on expanding our understanding of gene interactions 
and their functions as well as disease control by way of transmission blocking vaccine 
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development [71]. Furthermore, uncharacterized chemotypes that possess activity 
against sexual parasites have also been recently identified to inhibit transmission to 
mosquito and human contact [68]. Interference by JmjC inhibitor known as ML324 
causes expression to subsequently cease methylation activity followed by gametocyte 
lysis for P. falciparum. Identifying key surface proteins present in multi-parasite life 
rostrums could potentially be means of a preventative antimalarial against gameto-
cytes [68].
4. Conclusions
To date, gametocytogenesis and gametocyte transmission tracking remain 
largely uncharacterized due to low prevalence and technological hurdles. As several 
countries approach the elimination phase for malaria, the need for sensitive and 
reliable biomarkers for gametocyte detection is more urgent than ever. Microscopy 
has low detection limit to overcome low parasitemia loads and existing qPCR 
biomarkers fail to accurately detect both sexes of the parasites. Information on 
genetic polymorphisms and expression levels of gametocyte biomarkers enable 
researchers to develop a more sensitive and accurate diagnostic test for Plasmodium 
gametocytes. Knowledge of gametocyte reservoirs and their interactions with host 
immune system will help develop effective treatment and preventive strategies to 
minimize the risk of malaria transmission. We recommend future studies focus on 
gene interactions and protein functions involved in gametocyte development, as 
well as polymorphisms in novel gametocyte genes that could be targets for develop-
ing better diagnostics or transmission blocking vaccines.
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